RIPK3 and B-cell chronic lymphocytic leukemia: GA101 mediated cell death is caspase-independent (data not shown) [31], and we tested if the mechanism is necroptosis-related by applying necrostatin-1 and GSK’872, RIPK1 and RIPK3 inhibitors separately in prolonged CD40 stimulated CLL cells.